# | Drug | Count |
---|---|---|
0 | METHOTREXATE SODIUM | 53 |
1 | PREDNISONE | 52 |
2 | HYDROXYCHLOROQUINE SULFATE | 51 |
3 | METHOTREXATE | 49 |
4 | ADALIMUMAB | 48 |
5 | CETIRIZINE HYDROCHLORIDE | 47 |
6 | DICLOFENAC | 47 |
7 | DICLOFENAC SODIUM | 47 |
8 | ETANERCEPT | 47 |
9 | LEFLUNOMIDE | 47 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 6 | 0.0240 |
1 | HYDROCORTISONE PROBUTATE | 1 | 0.0217 |
2 | CAFFEINE CITRATE | 18 | 0.0179 |
3 | PSEUDOEPHEDRINE HYDROCHLORIDE | 37 | 0.0084 |
4 | CORTISONE ACETATE | 46 | 0.0069 |
5 | PSEUDOEPHEDRINE HCL | 37 | 0.0068 |
6 | DICLOFENAC POTASSIUM TABLETS | 17 | 0.0064 |
7 | RITUXIMAB-PVVR | 5 | 0.0053 |
8 | CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 10 | 0.0051 |
9 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 1 | 0.0046 |
# | Drug class | Count |
---|---|---|
0 | Corticosteroid [EPC] | 54 |
1 | CD20-directed Cytolytic Antibody [EPC] | 51 |
2 | Folate Analog Metabolic Inhibitor [EPC] | 49 |
3 | Aminosalicylate [EPC] | 47 |
4 | Antirheumatic Agent [EPC] | 47 |
5 | Tumor Necrosis Factor Blocker [EPC] | 47 |
6 | Interleukin-6 Receptor Antagonist [EPC] | 46 |
7 | Selective T Cell Costimulation Modulator [EPC] | 46 |
8 | Vitamin B12 [EPC] | 45 |
9 | Vitamin C [EPC] | 45 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Endoglycosidase [EPC] | 1 | 0.0006 |
1 | Antirheumatic Agent [EPC] | 47 | 0.0006 |
2 | Interleukin-6 Receptor Antagonist [EPC] | 46 | 0.0005 |
3 | Aminosalicylate [EPC] | 47 | 0.0005 |
4 | Selective T Cell Costimulation Modulator [EPC] | 46 | 0.0005 |
5 | Histamine-1 Receptor Antagonist [EPC] | 15 | 0.0004 |
6 | Methylxanthine [EPC] | 17 | 0.0004 |
7 | Interleukin-12 Antagonist [EPC] | 29 | 0.0004 |
8 | Purine Antimetabolite [EPC] | 24 | 0.0004 |
9 | Interleukin-23 Antagonist [EPC] | 29 | 0.0003 |